I think you' re correct, Early clinical trial studies being done by companies with little wherewithal to last to late stage trials are being valued at 0. That is why CRVS trades at less than cash. I have bar-belled a portion of my portfolio to include these cheap lottery ticket speculative stocks such as CRVS. On the other side I maintain long term dividend paying stalwarts.